胃癌早筛龙头觅瑞（Mirxes）今日股价强势上涨7.77%，市场表现亮眼。其背后核心驱动在于公司近期接连获得泰国与中国市场顶级战略客户，商业化突破获得关键验证。具体而言，在国内市场，觅瑞与大型央企——中铁物贸集团达成合作，为其员工群体提供胃癌早筛服务。此举标志着公司创新产品成功切入国内大型企业健康管理市场，具备重要示范意义。在海外拓展上，公司也取得显著的里程碑式进展——与泰国最大医疗集团BDMS...
Source Link胃癌早筛龙头觅瑞（Mirxes）今日股价强势上涨7.77%，市场表现亮眼。其背后核心驱动在于公司近期接连获得泰国与中国市场顶级战略客户，商业化突破获得关键验证。具体而言，在国内市场，觅瑞与大型央企——中铁物贸集团达成合作，为其员工群体提供胃癌早筛服务。此举标志着公司创新产品成功切入国内大型企业健康管理市场，具备重要示范意义。在海外拓展上，公司也取得显著的里程碑式进展——与泰国最大医疗集团BDMS...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.